Most Profitable ARCA Pharmaceutical Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
 0.01 
 1.14 
 0.01 
2NVO Novo Nordisk AS
100.99 B
(0.11)
 3.22 
(0.35)
3RDY Dr Reddys Laboratories
55.68 B
(0.03)
 1.57 
(0.05)
4JNJ Johnson Johnson
14.07 B
 0.03 
 1.12 
 0.03 
5NVS Novartis AG ADR
11.94 B
 0.04 
 1.24 
 0.05 
6LLY Eli Lilly and
10.59 B
 0.14 
 1.88 
 0.27 
7AZN AstraZeneca PLC ADR
8.69 B
 0.21 
 1.23 
 0.25 
8PFE Pfizer Inc
8.03 B
 0.06 
 1.38 
 0.08 
9SNY Sanofi ADR
5.4 B
 0.14 
 1.49 
 0.20 
10GSK GlaxoSmithKline PLC ADR
4.93 B
 0.08 
 1.72 
 0.13 
11ABBV AbbVie Inc
4.87 B
 0.19 
 1.41 
 0.27 
12ZTS Zoetis Inc
2.5 B
(0.12)
 1.44 
(0.17)
13OGN Organon Co
1.02 B
 0.02 
 2.63 
 0.05 
14RPRX Royalty Pharma Plc
858.98 M
 0.20 
 1.90 
 0.39 
15JAZZ Jazz Pharmaceuticals PLC
414.83 M
 0.14 
 1.56 
 0.23 
16ALKS Alkermes Plc
367.07 M
 0.24 
 1.91 
 0.45 
17MRK Merck Company
365 M
(0.13)
 1.69 
(0.22)
18PBH Prestige Brand Holdings
209.34 M
 0.05 
 2.27 
 0.11 
19VTRS Viatris
54.7 M
(0.22)
 1.29 
(0.28)
20PRGO Perrigo Company PLC
(12.7 M)
(0.09)
 1.47 
(0.13)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.